Additionally, they proved that Sema3G inhibited HFD-induced obesity through the PI3K/Akt/GSK3β signaling pathway in adipose tissue and the AMPK/SREBP-1c pathway in the liver. This evidence concerns the gene SEMA3G and obesity disorder.